Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/60638
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | A zebrafish melanophore model of amyloidβ toxicity |
Other Titles: | A zebrafish melanophore model of amyloid beta toxicity |
Author: | Newman, M. Wilson, L. Camp-Dotlic, E. Verdile, G. Martins, R. Lardelli, M. |
Citation: | Zebrafish, 2010; 7(2):155-159 |
Publisher: | Mary Ann Liebert, Inc. Publishers |
Issue Date: | 2010 |
ISSN: | 1545-8547 1557-8542 |
Statement of Responsibility: | Morgan Newman, Lachlan Wilson, Esther Camp, Giuseppe Verdile, Ralph Martins and Michael Lardelli |
Abstract: | Reliable animal models are required to facilitate the understanding of neurodegenerative pathways in Alzheimer's disease. Animal models can also be employed to search for disease-modifying drugs. The embryos and larvae of zebrafish are particularly advantageous for this purpose. For Alzheimer's disease, drugs that can ameliorate amyloidβ (Aβ) toxicity have therapeutic and/or prophylactic potential. We attempted to generate a zebrafish model of Aβ toxicity that would be viable and fertile but have a highly visible pigmentation phenotype in larvae. The larvae could then be arrayed in microtiter plates to screen compound libraries for drugs acting to reduce Aβ toxicity. We used the promoter of the zebrafish mitfa (nacre) gene to drive expression of the pathological 42 amino acid species of human Aβ, Aβ42, specifically in the highly visible melanophores (melanocytes) of transgenic zebrafish. However, the transgenic fish only showed an aberrant pigment phenotype in adults at the advanced age of 16 months. Nevertheless, our results show that alteration of zebrafish pigment pattern may be useful for analysis of toxic peptide action. |
Keywords: | Animals Zebrafish Alzheimer Disease Disease Models, Animal Zebrafish Proteins DNA Primers Pigmentation In Situ Hybridization Gene Transfer Techniques Polymerase Chain Reaction Microphthalmia-Associated Transcription Factor Drug Discovery Amyloid beta-Peptides |
Rights: | Copyright © 2010, Mary Ann Liebert, Inc. publishers |
DOI: | 10.1089/zeb.2009.0628 |
Published version: | http://dx.doi.org/10.1089/zeb.2009.0628 |
Appears in Collections: | Aurora harvest 5 Molecular and Biomedical Science publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.